Alliance formed to cure glioblastoma with personalized medicine
A new-generation clinical trial for glioblastoma multiforme (GBM) — the deadliest form of brain cancer – will begin enrolling patients...
CLL survival greatly improved by ibrutinib
A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL)...
Why some drugs don’t work against pancreatic cancer
An MD Anderson study may explain why chemotherapy drugs such as gemcitabine are ineffective against pancreatic cancer in some...
This gene could unlock an immune attack on cancer
A team led by researchers at MD Anderson Cancer Center reports a crucial tumor-thwarting gene protects an immune attack against lung...
Innovations in the OR
A cadre of elite surgeons is making a mark as pioneering researchers at MD Anderson. In the operating room, they’re not just excising...
Some colorectal cancers recur after treatment. But why?
Cetuximab, marketed as Erbitux®å, is one of the key therapies for metastatic colorectal cancer. Yet the cancer still returns in some...
How you cook meat could cause cancer
Diets high in meats cooked by high-temperature techniques such as barbecuing and pan-frying, which produce carcinogenic compounds, may...
Big collaboration based on nano-sized particles
Leveraging recent advances in the biology of extracellular vesicles and their role in intercellular communication, Codiak BioSciences,...
CPRIT grants continue to fuel the cancer fight
MD Anderson Cancer Center was awarded more than $22 million in research grants in November from the Cancer Prevention and Research...
Two faculty members named AAAS Fellows
Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer...